JP2020529193A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020529193A5 JP2020529193A5 JP2019571019A JP2019571019A JP2020529193A5 JP 2020529193 A5 JP2020529193 A5 JP 2020529193A5 JP 2019571019 A JP2019571019 A JP 2019571019A JP 2019571019 A JP2019571019 A JP 2019571019A JP 2020529193 A5 JP2020529193 A5 JP 2020529193A5
- Authority
- JP
- Japan
- Prior art keywords
- dna
- amount
- subject
- threshold
- previous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (27)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762522560P | 2017-06-20 | 2017-06-20 | |
| US201762522556P | 2017-06-20 | 2017-06-20 | |
| US201762522547P | 2017-06-20 | 2017-06-20 | |
| US62/522,560 | 2017-06-20 | ||
| US62/522,547 | 2017-06-20 | ||
| US62/522,556 | 2017-06-20 | ||
| US201762542790P | 2017-08-08 | 2017-08-08 | |
| US201762542787P | 2017-08-08 | 2017-08-08 | |
| US62/542,787 | 2017-08-08 | ||
| US62/542,790 | 2017-08-08 | ||
| US201762546848P | 2017-08-17 | 2017-08-17 | |
| US201762546872P | 2017-08-17 | 2017-08-17 | |
| US201762546798P | 2017-08-17 | 2017-08-17 | |
| US62/546,872 | 2017-08-17 | ||
| US62/546,848 | 2017-08-17 | ||
| US62/546,798 | 2017-08-17 | ||
| US201762571715P | 2017-10-12 | 2017-10-12 | |
| US201762571709P | 2017-10-12 | 2017-10-12 | |
| US62/571,709 | 2017-10-12 | ||
| US62/571,715 | 2017-10-12 | ||
| US201762576641P | 2017-10-24 | 2017-10-24 | |
| US62/576,641 | 2017-10-24 | ||
| US201862632960P | 2018-02-20 | 2018-02-20 | |
| US62/632,960 | 2018-02-20 | ||
| US201862653261P | 2018-04-05 | 2018-04-05 | |
| US62/653,261 | 2018-04-05 | ||
| PCT/US2018/038604 WO2018237078A1 (en) | 2017-06-20 | 2018-06-20 | Assessing conditions in transplant subjects using donor-specific cell-free dna |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020529193A JP2020529193A (ja) | 2020-10-08 |
| JP2020529193A5 true JP2020529193A5 (https=) | 2021-07-29 |
Family
ID=63047415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019571019A Pending JP2020529193A (ja) | 2017-06-20 | 2018-06-20 | ドナー特異的セルフリーｄｎａを用いる移植対象における状態の評価 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210139988A1 (https=) |
| EP (1) | EP3642367A1 (https=) |
| JP (1) | JP2020529193A (https=) |
| CN (1) | CN111094593A (https=) |
| AU (1) | AU2018288835A1 (https=) |
| CA (1) | CA3067634A1 (https=) |
| IL (1) | IL271458A (https=) |
| WO (1) | WO2018237078A1 (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
| US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| EP2572003A4 (en) | 2010-05-18 | 2016-01-13 | Natera Inc | METHOD FOR NONINVASIVE PRANATAL PLOIDIE ASSIGNMENT |
| US12152275B2 (en) | 2010-05-18 | 2024-11-26 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US12221653B2 (en) | 2010-05-18 | 2025-02-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| WO2012088456A2 (en) | 2010-12-22 | 2012-06-28 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| AU2011358564B9 (en) | 2011-02-09 | 2017-07-13 | Natera, Inc | Methods for non-invasive prenatal ploidy calling |
| US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
| EP3957749A1 (en) | 2014-04-21 | 2022-02-23 | Natera, Inc. | Detecting tumour specific mutations in biopsies with whole exome sequencing and in cell-free samples |
| US20180173845A1 (en) | 2014-06-05 | 2018-06-21 | Natera, Inc. | Systems and Methods for Detection of Aneuploidy |
| WO2016183106A1 (en) | 2015-05-11 | 2016-11-17 | Natera, Inc. | Methods and compositions for determining ploidy |
| WO2017181202A2 (en) | 2016-04-15 | 2017-10-19 | Natera, Inc. | Methods for lung cancer detection |
| US11485996B2 (en) | 2016-10-04 | 2022-11-01 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
| GB201618485D0 (en) | 2016-11-02 | 2016-12-14 | Ucl Business Plc | Method of detecting tumour recurrence |
| US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
| AU2018288832B2 (en) | 2017-06-20 | 2025-03-06 | The Medical College Of Wisconsin, Inc. | Assessing transplant complication risk with total cell-free DNA |
| JP2021506342A (ja) | 2017-12-14 | 2021-02-22 | ティーエーアイ ダイアグノスティックス インコーポレイテッドＴａｉ Ｄｉａｇｎｏｓｔｉｃｓ，Ｉｎｃ． | 移植のための移植片適合性の評価 |
| CA3090426A1 (en) | 2018-04-14 | 2019-10-17 | Natera, Inc. | Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna |
| US12234509B2 (en) | 2018-07-03 | 2025-02-25 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
| WO2020206292A2 (en) * | 2019-04-03 | 2020-10-08 | The Medical College Of Wisconsin, Inc. | Assessing conditions in transplant subjects using donor-specific cell-free dna |
| US11931674B2 (en) | 2019-04-04 | 2024-03-19 | Natera, Inc. | Materials and methods for processing blood samples |
| EP3980559A1 (en) | 2019-06-06 | 2022-04-13 | Natera, Inc. | Methods for detecting immune cell dna and monitoring immune system |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE052213T2 (hu) * | 2009-11-06 | 2021-04-28 | Univ Leland Stanford Junior | Grafitkilökõdés nem invazív diagnosztizálása szervátültetett betegekben |
| AU2013249012B2 (en) * | 2012-04-19 | 2019-03-28 | The Medical College Of Wisconsin, Inc. | Highly sensitive surveillance using detection of cell free DNA |
| EP3041955A4 (en) * | 2013-09-06 | 2017-05-03 | Immucor GTI Diagnostics, Inc. | Compositions and methods for diagnosis and prediction of solid organ graft rejection |
| WO2015058194A1 (en) * | 2013-10-18 | 2015-04-23 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Allele specific pcr assay for detection of nucleotide variants |
| WO2015069933A1 (en) * | 2013-11-06 | 2015-05-14 | The Board Of Trustees Of The Leland Stanford Junior University | Circulating cell-free dna for diagnosis of transplant rejection |
| WO2016123698A1 (en) * | 2015-02-06 | 2016-08-11 | Uti Limited Partnership | Diagnostic assay for post-transplant assessment of potential rejection of donor organs |
| US20180142296A1 (en) | 2015-04-30 | 2018-05-24 | Medical College Of Wisconsin, Inc. | Multiplexed optimized mismatch amplification (moma)-real time pcr for assessing cell-free dna |
-
2018
- 2018-06-20 AU AU2018288835A patent/AU2018288835A1/en not_active Abandoned
- 2018-06-20 CA CA3067634A patent/CA3067634A1/en active Pending
- 2018-06-20 WO PCT/US2018/038604 patent/WO2018237078A1/en not_active Ceased
- 2018-06-20 EP EP18747030.7A patent/EP3642367A1/en active Pending
- 2018-06-20 JP JP2019571019A patent/JP2020529193A/ja active Pending
- 2018-06-20 US US16/623,719 patent/US20210139988A1/en active Pending
- 2018-06-20 CN CN201880049767.XA patent/CN111094593A/zh active Pending
-
2019
- 2019-12-16 IL IL271458A patent/IL271458A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020529193A5 (https=) | ||
| JP2020524519A5 (https=) | ||
| JP2020529194A5 (https=) | ||
| Azakie et al. | Improving outcomes of the Fontan operation in children with atrial isomerism and heterotaxy syndromes | |
| JP2020529193A (ja) | ドナー特異的セルフリーｄｎａを用いる移植対象における状態の評価 | |
| Kiamanesh et al. | The state of the heart biopsy: a clinical review | |
| van SUYLEN et al. | The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease | |
| Theuerle et al. | Utility of the ACC/AHA lesion classification as a predictor of procedural, 30‐day and 12‐month outcomes in the contemporary percutaneous coronary intervention era | |
| KR102347561B1 (ko) | 우울증과 연관된 급성관상동맥증후군 장기예후 검사방법 및 진단키트 | |
| Daud et al. | Microvascular loss and diastolic dysfunction in severe symptomatic cardiac allograft vasculopathy | |
| Beller et al. | Does preoperative troponin level impact outcomes after coronary artery bypass grafting? | |
| Chopra et al. | Emerging role of cell-free DNA in kidney transplantation | |
| Grauhan et al. | Donor-transmitted coronary atherosclerosis | |
| Kanamori et al. | Noninvasive graft monitoring using donor‐derived cell‐free DNA in Japanese liver transplantation | |
| Richmond et al. | Validation of donor fraction cell-free DNA with biopsy-proven cardiac allograft rejection in children and adults | |
| Harskamp et al. | Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgery | |
| Lietz et al. | Current understanding and management of allograft vasculopathy | |
| Deshpande et al. | Evaluating threshold for donor fraction cell‐free DNA using clinically available assay for rejection in pediatric and adult heart transplantation | |
| Bonnet et al. | Sudden cardiac death after heart transplantation: a population-based study | |
| Isbir et al. | Association Between Angiotensin‐Converting Enzyme Gene Polymorphism and Coronary Artery Disease | |
| Doucet et al. | Outcomes of left main revascularization in patients with acute coronary syndromes and stable ischemic heart disease: analysis from the EXCEL trial | |
| Pradhan et al. | Telomere length is associated with adverse atrial remodeling in patients with atrial fibrillation | |
| Floré et al. | Intravascular ultrasound of the proximal left anterior descending artery is sufficient to detect early cardiac allograft vasculopathy | |
| Angelini et al. | Discordance between pre and post cardiac transplant diagnosis: implications for pre-and postoperative decision making | |
| Corti et al. | Potential of real-time PCR assessment of granzyme B and perforin up-regulation for rejection monitoring in intestinal transplant recipients |